Senate Bill No. 2173 Summary

• Licensed pharmacists in institutional settings may initiate or modify drug therapy following diagnosis and initial assessment by a licensed physician or advanced practice registered nurse, with access to patient medical records and supervision.

• Pharmacists and physicians or advanced practice registered nurses must prepare and update collaborative agreements at least every four years, with approval required from the board of medical examiners or board of nursing and the board of pharmacy.

• Collaborative agreements may be established between a medical director and pharmacist-in-charge, who must report covered personnel to their respective licensing boards and provide immediate notice of personnel changes.

• Pharmacists must immediately notify the physician or advanced practice registered nurse when initiating or modifying drug therapy, with care recorded and communicated in patient medical records.

• The board of medical examiners and board of pharmacy must jointly establish a prescriptive practices committee to develop proposed rules for implementing these provisions, with rules requiring joint adoption by both boards.